Active Ingredient(s): Alefacept
FDA Approved: * January 30, 2003
Pharm Company: * BIOGEN
Category: Skin Care

Alefacept is a genetically engineered immunosuppressive drug. It was sold under the brand name Amevive in Canada, the United States, Israel, Switzerland and Australia. In 2011, the manufacturers made a decision to cease promotion, manufacturing, distribution and sales of Amevive during a supply disruption. According to Astellas Pharma US, Inc.,[1] the decision to cease Amevive sales was neither the result of any specific safety concern nor the result of any FDA-mandated or vol... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.